Organon presents tapinarof cream data across age groups at SPD meeting

July 24, 2026 8:00 AM

Organon (NYSE: OGN) presented results from a post hoc analysis of pooled Phase 3 data for its tapinarof cream, 1 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found